22 bed full continuum SUD treatment center, dual diagnosis, Joint Commission accredited
$5 million revenue; $1 million EBITDA
In-network with excellent rates
Great local and regional referral sources and desirable niche market, solid census and numbers, real estate possible, wonderful opportunity, great timing for investor